Abstract
Trypan blue and suramin inhibit receptor-mediated endocytosis of vitellogenin in Locusta migratoria. Both drugs bind to cationic side chains of the vitellogenin molecule, which are presumably also the binding sites for the specific vitellogenin receptor. Thus binding of vitellogenin to the receptor is prevented in isolated oocytes and in oocyte membrane preparations. Small amounts of trypan blue may unspecifically enter oocytes by "piggy-back" endocytosis. Suramin has a high affinity for vitellogenin and in contrast to trypan blue it does not form insoluble complexes with the protein. Therefore, it may be a useful tool for further analysis of the locust vitellogenin receptor.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
